Patent · US Active

Autotaxin inhibitors

US8329907B2 · kind B2 · utility

32Cited by

0References

8Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Melanie Schultz · Darmstadt, DE
Kai Schiemann · Darmstadt, DE
Wolfgang Staehle · Ingelheim am Rhein, DE

Key dates

Filing date	Mar 9, 2010
Grant date	Dec 11, 2012
Priority date	—
Expiry date	Mar 9, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds according to formula (I) as autotaxin inhibitors and the use of such compounds for the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by increased lysophosphatic acid levels and/or the activation of autotaxin, in particular of different cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.